x

Search for a networks

* (*) mandatory field

A randomized, double-blinded, regimen controlled, phase II, multicenter study to assess the efficacy and safety of two different Vismodegib regimens in patients with multiple Basal Cell Carcinoma

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : HOFFMANN - LA ROCHE LTD. 
  • Sponsor : Not yet identified
Last update: November 2013

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.